Here you can get the latest information on the coronavirus, or COVID-19, in North Carolina and surrounding region, and resources to be prepared and keep your family safe.
Click the video player above for the latest information from Gov. Roy Cooper.
Sign up for our Newsletters
What’s New — Week of Oct. 25:
- More than 9.0 million people in the country have been infected with the virus and more than 230,000 people have died, according to data from Johns Hopkins University.
- The latest surge of COVID-19 infections has brought the seven-day average of new daily cases to heights not seen since the pandemic began. The seven-day average of new cases hit 68,767 on Sunday, topping the previous peak of 67,293 reported on July 22. The two highest single days of new cases were Friday and Saturday, with more than 83,000 new cases added each day.
- The economic fallout of the COVID-19 pandemic is driving up food insecurity across America. 54 million Americans are going hungry. Here is how you can get help if you are facing food insecurity today.
- Immunity to COVID-19 infection lingers for at least five months, researchers reported — and probably longer than that.
- As voters get ready to head to the polls on Election Day, many will do something they have never done before: put on a mask to go vote. Here are coronavirus guidelines for in-person voting.
- Gov. Roy Cooper issued Executive Order No. 171 Wednesday to strengthen eviction protections and keep more North Carolinians in their homes.
- Millions of Americans who have lost health insurance in an economy shaken by the coronavirus can sign up for taxpayer-subsidized coverage starting Sunday.
North Carolina Numbers:
The North Carolina Department of Health and Human Services has not updated its coronavirus numbers for Friday because of a technical delay, it reported. It is working to provide an update as soon as possible, which is when this article will be updated.
- There have been 274,635 cases and 4,378 deaths in the state as of Saturday
- There are currently 1,184 people hospitalized
- The state has completed 4,043,698 tests
- 6.1% of tests returned positive, with 2,805 new cases reported Saturday
- Dr. Mandy Cohen, secretary of the Department of Health and Human Services, said the goal for this benchmark is 5%.
Piedmont Triad County Numbers:
- Alamance County has 5,511 positive cases, 89 deaths
- Alleghany County has 311 positive cases, 2 deaths
- Caswell County has 640 positive cases, 5 deaths
- Davidson County has 3,836 positive cases, 44 deaths
- Davie County has 786 positive cases, 11 deaths
- Forsyth County has 9,121 positive cases, 121 deaths
- Guilford County has 11,877 positive cases, 210 deaths
- Montgomery County has 1,208 positive cases, 40 deaths
- Randolph County has 3,921 positive cases, 64 deaths
- Rockingham County has 2,125 positive cases, 26 deaths
- Stokes County has 710 positive cases, 12 deaths
- Surry County has 1,961 positive cases, 33 deaths
- Wilkes County has 1,846 positive cases, 38 deaths
- Yadkin County has 1,084 positive cases,
A new antibody-based drug shows promise in treating outpatients who have mild to severe COVID-19, according to initial results of research conducted in part at Cook County Health and Northwestern University.
Patients given the drug were hospitalized or visited the emergency room less often than those given a placebo, Cook County Health officials said. The patients receiving the drug also showed improvement within two to six days, a shorter disease course that is not only good for patients but also may reduce the amount of time a person is infectious, helping protect other people.
The drug, manufactured by Eli Lilly and AbCellera Biologics Inc., was tested on 452 outpatients at 24 medical institutions across the country, including Cook County’s vast public health system and the Northwestern University Feinberg School of Medicine. Most of the 14 patients who took part at Cook County Health were Latino or Black, populations that have been hit especially hard by the disease.
The results of the continuing study, which is being run by Eli Lilly, were published Wednesday by the New England Journal of Medicine.
The drug, administered through a one-time infusion, includes the replicated antibodies of one of the first patients in the United States to survive COVID-19. It’s classified as a monoclonal antibody treatment, the same type of medication given to President Donald Trump after he was diagnosed with the disease and which he described as “a cure.”
The drug in the Eli Lilly trial was formulated using a single antibody. The drug Trump received was made by Regeneron and involves two antibodies.
Dr. Gregory Huhn, an infectious disease expert who led the arm of the Eli Lilly research conducted at Cook County Health, made it clear that the drug is a treatment, not a cure.
“Our hope has been that the antibody drug will reduce COVID symptoms quickly after diagnosis and help to eradicate the virus more quickly,” Huhn said. “While a vaccine is still necessary, this drug therapy has the potential to prevent bad clinical outcomes and complications of COVID-19.”
Scientists have surmised that monoclonal antibodies would be more effective earlier in the course of the disease, and that so far appears to be the case. Another recently released study found the Eli Lilly drug had no benefit for patients sick enough to be hospitalized — results that brought the research to a halt. Most of those patients also were treated with the antiviral drug remdesivir.
“There’s a more compelling argument to administer antibodies early on, before our own bodies generate their own immune response,” Huhn said.
The results released Wednesday found that 1.6% of outpatients given the Eli Lilly drug needed to be hospitalized or visit an emergency room, compared with 6.3% of patients who received a placebo. The drug worked by reducing the amount of virus in people’s bodies, the study determined.
The study’s findings also indicate better outcomes among high-risk patients — defined as patients 65 or older or morbidly obese patients who were at least